Pediatric Depression Workup

1. American Psychiatric Association. Depressive Disorders. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2021.

2. Birmaher B, Ryan ND, Williamson DE, et al. Childhood and adolescent depression: a review of the past 10 years. Part I. J Am Acad Child Adolesc Psychiatry. 1996 Nov. 35(11):1427-39. [QxMD MEDLINE Link].

3. Birmaher B, Ryan ND, Williamson DE, et al. Childhood and adolescent depression: a review of the past 10 years. Part II. J Am Acad Child Adolesc Psychiatry. 1996 Dec. 35(12):1575-83. [QxMD MEDLINE Link].

4. Drevets WC, Price JL, Simpson JR, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 1997 Apr 24. 386(6627):824-7. [QxMD MEDLINE Link].

5. Hendren RL, De Backer I, Pandina GJ. Review of neuroimaging studies of child and adolescent psychiatric disorders from the past 10 years. J Am Acad Child Adolesc Psychiatry. 2000 Jul. 39(7):815-28. [QxMD MEDLINE Link].

6. Steingard RJ, Renshaw PF, Yurgelun-Todd D, et al. Structural abnormalities in brain magnetic resonance images of depressed children. J Am Acad Child Adolesc Psychiatry. 1996 Mar. 35(3):307-11. [QxMD MEDLINE Link].

7. Tutus A, Kibar M, Sofuoglu S, et al. A technetium-99m hexamethylpropylene amine oxime brain single-photon emission tomography study in adolescent patients with major depressive disorder. Eur J Nucl Med. 1998 Jun. 25(6):601-6. [QxMD MEDLINE Link].

8. Nobile M, Begni B, Giorda R, et al. Effects of serotonin transporter promoter genotype on platelet serotonin transporter functionality in depressed children and adolescents. J Am Acad Child Adolesc Psychiatry. 1999 Nov. 38(11):1396-402. [QxMD MEDLINE Link].

9. Birmaher B, Kaufman J, Brent DA, et al. Neuroendocrine response to 5-hydroxy-L-tryptophan in prepubertal children at high risk of major depressive disorder. Arch Gen Psychiatry. 1997 Dec. 54(12):1113-9. [QxMD MEDLINE Link].

10. De Bellis MD, Dahl RE, Perel JM, et al. Nocturnal ACTH, cortisol, growth hormone, and prolactin secretion in prepubertal depression. J Am Acad Child Adolesc Psychiatry. 1996 Sep. 35(9):1130-8. [QxMD MEDLINE Link].

11. Akiskal HS, Weller ES. Mood disorders and suicide in children and adolescents. Kaplan HI, Saddock BJ, eds. Comprehensive Textbook of Psychiatry. 5th ed. Lippincott Williams & Wilkins; 1989. Vol 2:

12. Weissman MM, Leckman JF, Merikangas KR, et al. Depression and anxiety disorders in parents and children. Results from the Yale family study. Arch Gen Psychiatry. 1984 Sep. 41(9):845-52. [QxMD MEDLINE Link].

13. Bang KS, Chae SM, Hyun MS, et al. The mediating effects of perceived parental teasing on relations of body mass index to depression and self-perception of physical appearance and global self-worth in children. J Adv Nurs. 2012 Mar 4. [QxMD MEDLINE Link].

14. Hammen C, Burge D, Adrian C. Timing of mother and child depression in a longitudinal study of children at risk. J Consult Clin Psychol. 1991 Apr. 59(2):341-5. [QxMD MEDLINE Link].

15. Klerman GL, Weissman MM. Increasing rates of depression. JAMA. 1989 Apr 21. 261(15):2229-35. [QxMD MEDLINE Link].

16. Twenge JM, Joiner TE, Rogers ML, Martin GN. Increases in Depressive Symptoms, Suicide-Related Outcomes, and Suicide Rates Among U.S. Adolescents After 2010 and Links to Increased New Media Screen Time. Clin Psychol Sci. November 14, 2017. [Full Text].

17. Data and Statistics on Children’s Mental Health. Centers for Disease Control and Prevention. Available at https://www.cdc.gov/childrensmentalhealth/data.html. Accessed: Dec 12, 2022.

18. Perou R, Bitsko RH, Blumberg SJ, Pastor P, Ghandour RM, Gfroerer JC, et al. Mental health surveillance among children--United States, 2005-2011. MMWR Suppl. 2013 May 17. 62 (2):1-35. [QxMD MEDLINE Link].

19. Garrison CZ, Waller JL, Cuffe SP, et al. Incidence of major depressive disorder and dysthymia in young adolescents. J Am Acad Child Adolesc Psychiatry. 1997 Apr. 36(4):458-65. [QxMD MEDLINE Link].

20. Helgason T. Epidemiology of psychiatric disorders in Iceland. Nord J Psychiatry. 1996. 50:31-8.

21. Murphy JM, Laird NM, Monson RR, et al. Incidence of depression in the Stirling County Study: historical and comparative perspectives. Psychol Med. 2000 May. 30(3):505-14. [QxMD MEDLINE Link].

22. Copeland JR, Beekman AT, Dewey ME, et al. Depression in Europe. Geographical distribution among older people. Br J Psychiatry. 1999 Apr. 174:312-21. [QxMD MEDLINE Link].

23. Jablensky A, Sartorius N, Gulbinat W, Ernberg G. Characteristics of depressive patients contacting psychiatric services in four cultures. A report from the who collaborative study on the assessment of depressive disorders. Acta Psychiatr Scand. 1981 Apr. 63(4):367-83. [QxMD MEDLINE Link].

24. Kovacs M, Gatsonis C. Secular trends in age at onset of major depressive disorder in a clinical sample of children. J Psychiatr Res. 1994 May-Jun. 28(3):319-29. [QxMD MEDLINE Link].

25. Lewinsohn PM, Clarke GN, Seeley JR, Rhode P. Major depression in community adolescents: age at onset, episode duration, and time to recurrence. J Am Acad Child Adolesc Psychiatry. 1994 Jul-Aug. 33(6):809-18. [QxMD MEDLINE Link].

26. Lewinsohn PM, Hops H, Roberts RE, et al. Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students. J Abnorm Psychol. 1993 Feb. 102(1):133-44. [QxMD MEDLINE Link].

27. Lewinsohn PM, Rohde P, Klein DN, Seeley JR. Natural course of adolescent major depressive disorder: I. Continuity into young adulthood. J Am Acad Child Adolesc Psychiatry. 1999 Jan. 38(1):56-63. [QxMD MEDLINE Link].

28. Data Spotlight. Depression Triples between the Ages of 12 and 15 among Adolescent Girls. Substance Abuse and Mental Health Services Administration (SAMHSA). Available at http://www.samhsa.gov/data/spotlight/Spot077GirlsDepression2012.pdf. Accessed: October 15, 2012.

29. Kashani JH, Sherman DD. Childhood depression: Epidemiology, etiological models, and treatment implications. Integr Psychiatry. 1988. 6:1-8.

30. Hovey JD, King CA. Acculturative stress, depression, and suicidal ideation among immigrant and second-generation Latino adolescents. J Am Acad Child Adolesc Psychiatry. 1996 Sep. 35(9):1183-92. [QxMD MEDLINE Link].

31. Siegel JM, Aneshensel CS, Taub B. Adolescent depressed mood in a multiethnic sample. J Youth Adolesc. 1998. 27:

32. Brooks M. Depression Top Cause of Illness, Disability Among Teens: WHO. Medscape Medical News. May 14 2014. [Full Text].

33. WHO. Health for the World's Adolescents: A Second Chance in the Second Decade. World Health Organization. Available at http://apps.who.int/adolescent/second-decade/. Accessed: May 20 2014.

34. AACAP. Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. AACAP. J Am Acad Child Adolesc Psychiatry. 1998 Oct. 37(10 Suppl):63S-83S. [QxMD MEDLINE Link].

35. National Center for Injury Prevention and Control, Division of Violence Prevention. Suicide Facts at a Glance 2015. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/violenceprevention/pdf/suicide-datasheet-a.pdf. 2015; Accessed: March 15, 2016.

36. Asarnow JR, Porta G, Spirito A, et al. Suicide Attempts and Nonsuicidal Self-Injury in the Treatment of Resistant Depression in Adolescents: Findings from the TORDIA Study. J Am Acad Child Adolesc Psychiatry. 2011 Aug. 50(8):772-81. [QxMD MEDLINE Link]. [Full Text].

37. Cwik MF, Barlow A, Tingey L, Larzelere-Hinton F, Goklish N, Walkup JT. Nonsuicidal self-injury in an american Indian reservation community: results from the white mountain apache surveillance system, 2007-2008. J Am Acad Child Adolesc Psychiatry. 2011 Sep. 50(9):860-9. [QxMD MEDLINE Link].

38. Wickramaratne PJ, Greenwald S, Weissman MM. Psychiatric disorders in the relatives of probands with prepubertal- onset or adolescent-onset major depression. J Am Acad Child Adolesc Psychiatry. 2000 Nov. 39(11):1396-405. [QxMD MEDLINE Link].

39. Hooshmand S, Willoughby T, Good M. Does the direction of effects in the association between depressive symptoms and health-risk behaviors differ by behavior? A longitudinal study across the high school years. J Adolesc Health. 2012 Feb. 50(2):140-7. [QxMD MEDLINE Link].

40. Strober M, DeAntonio M, Schmidt-Lackner S, et al. The pharmacotherapy of depressive illness in adolescents: an open-label comparison of fluoxetine with imipramine-treated historical controls. J Clin Psychiatry. 1999 Mar. 60(3):164-9. [QxMD MEDLINE Link].

41. Ambrosini PJ, Wagner KD, Biederman J, et al. Multicenter open-label sertraline study in adolescent outpatients with major depression. J Am Acad Child Adolesc Psychiatry. 1999 May. 38(5):566-72. [QxMD MEDLINE Link].

42. Wagner KD, Ambrosini P, Rynn M, et al. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. JAMA. 2003 Aug 27. 290(8):1033-41. [QxMD MEDLINE Link].

43. Birmaher B, Brent DA, Kolko D, et al. Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder. Arch Gen Psychiatry. 2000 Jan. 57(1):29-36. [QxMD MEDLINE Link].

44. Brent DA, Kolko DJ, Birmaher B, et al. Predictors of treatment efficacy in a clinical trial of three psychosocial treatments for adolescent depression. J Am Acad Child Adolesc Psychiatry. 1998 Sep. 37(9):906-14. [QxMD MEDLINE Link].

45. Merry SN, Hetrick SE, Cox GR, Brudevold-Iversen T, Bir JJ, McDowell H. Psychological and educational interventions for preventing depression in children and adolescents. Cochrane Database Syst Rev. 2011 Dec 7. 12:CD003380. [QxMD MEDLINE Link].

46. Mihalopoulos C, Vos T, Pirkis J, et al. The population cost-effectiveness of interventions designed to prevent childhood depression. Pediatrics. 2012 Mar. 129(3):e723-30. [QxMD MEDLINE Link].

47. Clarke GN, Rohde P, Lewinsohn PM, et al. Cognitive-behavioral treatment of adolescent depression: efficacy of acute group treatment and booster sessions. J Am Acad Child Adolesc Psychiatry. 1999 Mar. 38(3):272-9. [QxMD MEDLINE Link].

48. Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev. 2006 Jan. 26(1):17-31. [QxMD MEDLINE Link].

49. Kroll L, Harrington R, Jayson D, et al. Pilot study of continuation cognitive-behavioral therapy for major depression in adolescent psychiatric patients. J Am Acad Child Adolesc Psychiatry. 1996 Sep. 35(9):1156-61. [QxMD MEDLINE Link].

50. Garber J, Clarke GN, Weersing VR, Beardslee WR, Brent DA, Gladstone TR, et al. Prevention of depression in at-risk adolescents: a randomized controlled trial. JAMA. 2009 Jun 3. 301(21):2215-24. [QxMD MEDLINE Link]. [Full Text].

51. Mufson L, Fairbanks J. Interpersonal psychotherapy for depressed adolescents: a one-year naturalistic follow-up study. J Am Acad Child Adolesc Psychiatry. 1996 Sep. 35(9):1145-55. [QxMD MEDLINE Link].

52. Barclay L. Efficacy of Antidepressant Medication vs Placebo Increases With Severity of Depression. Medscape Today. Available at http://www.medscape.com/viewarticle/715585. Accessed: February 4, 2010.

53. Fournier JC, DeRubeis RJ, Hollon ST, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. Available at http://jama.ama-assn.org/content/303/1/47.full. Accessed: February 4, 2010.

54. Taketomo CK, Hodding JH, Kraus DM. Pediatric Dosage Handbook. 7th ed. Hudson, Ohio: Lexi-Comp, Inc; 2000.

55. Harrison P. High-dose antidepressants in youth may up risk for self-harm. Medscape Medical News. April 28, 2014. [Full Text].

56. Miller M, Swanson SA, Azrael D, Pate V, Stürmer T. Antidepressant Dose, Age, and the Risk of Deliberate Self-harm. JAMA Intern Med. 2014 Apr 28. [QxMD MEDLINE Link].

57. Brent DA, Gibbons R. Initial Dose of Antidepressant and Suicidal Behavior in Youth: Start Low, Go Slow. JAMA Intern Med. 2014 Apr 28. [QxMD MEDLINE Link].

58. Leonard HL, March J, Rickler KC, Allen AJ. Pharmacology of the selective serotonin reuptake inhibitors in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1997 Jun. 36(6):725-36. [QxMD MEDLINE Link].

59. Rey-Sanchez F, Gutierrez-Casares JR. Paroxetine in children with major depressive disorder: an open trial. J Am Acad Child Adolesc Psychiatry. 1997 Oct. 36(10):1443-7. [QxMD MEDLINE Link].

60. Emslie GJ, Rush AJ, Weinberg WA, et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry. 1997 Nov. 54(11):1031-7. [QxMD MEDLINE Link].

61. Shamseddeen W, Clarke G, Wagner KD, et al. Treatment-Resistant Depressed Youth Show a Higher Response Rate if Treatment Ends During Summer School Break. J Am Acad Child Adolesc Psychiatry. 2011 Nov. 50(11):1140-8. [QxMD MEDLINE Link].

62. King RA, Segman RH, Anderson GM. Serotonin and suicidality: the impact of acute fluoxetine administration. I: Serotonin and suicide. Isr J Psychiatry Relat Sci. 1994. 31(4):271-9. [QxMD MEDLINE Link].

63. Teicher MH, Glod CA, Cole JO. Antidepressant drugs and the emergence of suicidal tendencies. Drug Saf. 1993 Mar. 8(3):186-212. [QxMD MEDLINE Link].

64. Newman TB. A black-box warning for antidepressants in children?. N Engl J Med. 2004 Oct 14. 351(16):1595-8. [QxMD MEDLINE Link].

65. Kurian BT, Ray WA, Arbogast PG, et al. Effect of regulatory warnings on antidepressant prescribing for children and adolescents. Arch Pediatr Adolesc Med. 2007 Jul. 161(7):690-6. [QxMD MEDLINE Link].

66. Cassels C. FDA Suicide Warnings Change Antidepressant Prescribing Patterns, but Physicians Ignore Monitoring Recommendations. Medscape Today. Available at http://www.medscape.com/viewarticle/715952. Accessed: February 4, 2010.

67. Cassels C. FDA Suicide Warnings About Antidepressants Cut Rates of Depression Diagnosis and Treatment. Medscape Today. Available at http://www.medscape.com/viewarticle/704235. Accessed: February 4, 2010.

68. Carlsten A, Waern M, Ekedahl A, Ranstam J. Antidepressant medication and suicide in Sweden. Pharmacoepidemiol Drug Saf. 2001 Oct-Nov. 10(6):525-30. [QxMD MEDLINE Link].

69. Hall WD, Mant A, Mitchell PB, et al. Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis. BMJ. 2003 May 10. 326(7397):1008. [QxMD MEDLINE Link]. [Full Text].

70. March J, Silva S, Petrycki S, et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA. 2004 Aug 18. 292(7):807-20. [QxMD MEDLINE Link].

71. Daly JM, Wilens T. The use of tricyclic antidepressants in children and adolescents. Pediatr Clin North Am. 1998 Oct. 45(5):1123-35. [QxMD MEDLINE Link].

72. Geller B, Reising D, Leonard HL, et al. Critical review of tricyclic antidepressant use in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1999 May. 38(5):513-6. [QxMD MEDLINE Link].

73. Hazell P, O'Connell D, Heathcote D, Robertson J, Henry D. Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis. BMJ. 1995 Apr 8. 310(6984):897-901. [QxMD MEDLINE Link].

74. Richardson LP, Ludman E, McCauley E, Lindenbaum J, Larison C, Zhou C, et al. Collaborative care for adolescents with depression in primary care: a randomized clinical trial. JAMA. 2014 Aug 27. 312(8):809-16. [QxMD MEDLINE Link].

75. Reeves GM, Riddle MA. A practical and effective primary care intervention for treating adolescent depression. JAMA. 2014 Aug 27. 312(8):797-8. [QxMD MEDLINE Link].

76. Beardslee WR, Brent DA, Weersing VR, Clarke GN, Porta G, Hollon SD, et al. Prevention of Depression in At-Risk Adolescents: Longer-term Effects. JAMA Psychiatry. 2013 Sep 4. [QxMD MEDLINE Link].

77. Brauser D. CBT effective in kids at ‘double risk’ for depression. Medscape Medical News. September 10, 2013;. Available at http://www.medscape.com/viewarticle/810742. Accessed: September 16, 2013.

Angelo P Giardino, MD, PhD, MPH, FAAP Wilma T Gibson Presidential Professor and Chair, Department of Pediatrics, University of Utah School of Medicine; Chief Medical Officer, Intermountain Primary Children's Hospital

Angelo P Giardino, MD, PhD, MPH, FAAP is a member of the following medical societies: Academic Pediatric Association, American Academy of Pediatrics, American Professional Society on the Abuse of Children, Harris County Medical Society, International Society for the Prevention of Child Abuse and Neglect, Ray E Helfer Society

Disclosure: Nothing to disclose.

Tami D Benton, MD Clinical Director, Child and Adolescent Psychiatry, Psychiatrist-in-Chief, Executive Director, Department of Child and Adolescent Psychiatry and Behavioral Science, Children's Hospital of Philadelphia

Tami D Benton, MD is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Caroly Pataki, MD Health Sciences Clinical Professor of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, David Geffen School of Medicine

Caroly Pataki, MD is a member of the following medical societies: American Academy of Child and Adolescent Psychiatry, New York Academy of Sciences, Physicians for Social Responsibility

Disclosure: Nothing to disclose.

Jacqueline Lynch, MSW, Research Assistant, Department of Child and Adolescent Psychiatry, Children's Hospital of Philadelphia

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article